Plasma insulin is required for the increase in plasma angiopoietin‐like protein 8 in response to nutrient ingestion
暂无分享,去创建一个
R. DeFronzo | M. Abu-Farha | J. Abubaker | F. Al-Mulla | M. Abdul-Ghani | L. Norton | E. Al-Ozairi | I. Al-Khairi | Preethi Cherian | John Adams | Mariam Alatrach | Siham Abdelgani | S. Abdelgani | Krisitn Agyin | D. AL-Saeed | E. Al‐Ozairi
[1] R. Siegel,et al. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif , 2022, Journal of lipid research.
[2] Ren Zhang,et al. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. , 2021, Progress in lipid research.
[3] B. Rodrigues,et al. Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart , 2021, Biomolecules.
[4] M. Rizzo,et al. Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease , 2021, Metabolites.
[5] K. Alzoubi,et al. Exploring perception and hesitancy toward COVID-19 vaccine: A study from Jordan , 2021, Human vaccines & immunotherapeutics.
[6] Y. Qian,et al. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition , 2021, Journal of lipid research.
[7] M. Prentki,et al. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. , 2020, Progress in lipid research.
[8] P. Cluzel,et al. High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects , 2020, Diabetes/metabolism research and reviews.
[9] F. V. van’t Hooft,et al. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids[S] , 2020, Journal of Lipid Research.
[10] M. Abdul-Ghani,et al. Regulation of ANGPTL8 in Liver and Adipose Tissue by Nutritional and Hormonal Signals and its Effect on Glucose Homeostasis in Mice. , 2020, American journal of physiology. Endocrinology and metabolism.
[11] M. Ploug,et al. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity , 2019, Journal of Lipid Research.
[12] S. Kalyon,et al. Serum Angiopoietin‐like peptide 4 levels in patients with hepatic steatosis , 2018, Cytokine.
[13] J. Tuomilehto,et al. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases , 2017, Diabetes/metabolism research and reviews.
[14] S. Kersten. Angiopoietin-like 3 in lipoprotein metabolism , 2017, Nature Reviews Endocrinology.
[15] S. Shetty,et al. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase , 2017, Molecular metabolism.
[16] Jonathan C. Cohen,et al. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance[S] , 2017, Journal of Lipid Research.
[17] Mingfeng Xia,et al. Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population , 2017, PloS one.
[18] Ren Zhang. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking , 2016, Open Biology.
[19] M. Abu-Farha,et al. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome , 2016, Cardiovascular Diabetology.
[20] P. Fischer-Posovszky,et al. Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin. , 2015, The Journal of clinical endocrinology and metabolism.
[21] F. Hu,et al. Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance , 2015, Scientific Reports.
[22] Indra Ramasamy,et al. Recent advances in physiological lipoprotein metabolism , 2014, Clinical chemistry and laboratory medicine.
[23] Libin Zhou,et al. Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients , 2014, Diabetes Care.
[24] F. Sacks,et al. Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus: A Global Case–Control Study in 13 Countries , 2013, Circulation.
[25] Jonathan C. Cohen,et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis , 2013, Proceedings of the National Academy of Sciences.
[26] Y. Li,et al. Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study , 2013, Cardiovascular Diabetology.
[27] Jonathan C. Cohen,et al. Atypical angiopoietin-like protein that regulates ANGPTL3 , 2012, Proceedings of the National Academy of Sciences.
[28] Ji Young Kim,et al. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. , 2012, American journal of physiology. Endocrinology and metabolism.
[29] P. Tso,et al. The mechanism of the formation and secretion of chylomicrons. , 2010, Atherosclerosis. Supplements.
[30] A. Mooradian. Dyslipidemia in type 2 diabetes mellitus , 2009, Nature Clinical Practice Endocrinology &Metabolism.
[31] Robert A. Hegele,et al. Plasma lipoproteins: genetic influences and clinical implications , 2009, Nature Reviews Genetics.
[32] C. Fraser,et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.
[33] Sanjoy Ghosh,et al. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. , 2003, Journal of molecular and cellular cardiology.
[34] P. Sluijs,et al. How proteins move lipids and lipids move proteins , 2001, Nature Reviews Molecular Cell Biology.
[35] R. DeFronzo,et al. Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance Results From the Veterans Administration Genetic Epidemiology Study , 2006 .
[36] R. DeFronzo,et al. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. , 2006, Diabetes care.